Carla Rizzo

Dr. Carla Rizzo

Dipartimento di Scienze e Tecnologie Biologiche, Università degli Studi di Palermo, Palermo, Italy
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2021 in ACS Sustainable Chemistry & Engineering
Verified
Journal Article
Open access
Salvatore MarulloSalvatore Marullo
Salvatore Marullo
Carla RizzoCarla Rizzo
Carla Rizzo
Nadka Tzankova DintchevaNadka Tzankova Dintcheva
Nadka Tzankova Dintcheva
Francesca D'AnnaFrancesca D'Anna
Francesca D'Anna
Chemical recycling to monomers is one of the key strategies in tackling the issues deriving from persistent plastic pollution in the environment, and poly(ethylene terephthalate) (PET) is among the most used polymers in modern society. In this context, we herein describe the glycolysis of PET to bis-hydroxyethyl terephthalate (BHET), promoted by basic cholinium salts differing for the anions, also comprising amino acid anions. We investigated the optimal reaction conditions, finding that the best-performing catalyst is [Ch][Gly], in the presence of which a conversion of 85% and a yield of 51% are achieved at 150 °C after 6 h, from PET deriving from a clear water bottle. We used our protocol to carry out the glycolysis of PET deriving from different postconsumer waste, like opaque and colored bottles and food packages, finding that the performance is better in the former compared with the latter starting materials.

Verified
Journal Article
Open access
PDF file
Carla RizzoCarla Rizzo
Carla Rizzo
SASara Amata
Sara Amata
IPIvana Pibiri
Ivana Pibiri
Andrea PaceAndrea Pace
Andrea Pace
SBSilvestre Buscemi
Silvestre Buscemi
Antonio Palumbo PiccionelloAntonio Palumbo Piccionello
Antonio Palumbo Piccionello
The inclusion of fluorine atoms or heterocyclic moiety into drug structures represents a recurrent motif in medicinal chemistry. The combination of these two features is constantly appearing in new molecular entities with various biological activities. This is demonstrated by the increasing number of newly synthesized fluorinated heterocyclic compounds among the Food and Drug Administration FDA-approved drugs. In this review, the biological activity, as well as the synthetic aspects, of 33 recently FDA-approved fluorinated heterocyclic drugs from 2016 to 2022 are highlighted.

5 January 2018 in ACS Nano
Verified
Journal Article
Closed access
Carla RizzoCarla Rizzo
Carla Rizzo
FAFrancesca Arcudi
Francesca Arcudi
LĐLuka Đorđević
Luka Đorđević
NDNadka Tzankova Dintcheva
Nadka Tzankova Dintcheva
RNRenato Noto
Renato Noto
MPMaurizio Prato
Maurizio Prato

1 May 2018 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
Salvatore MarulloSalvatore Marullo
Salvatore Marullo
Carla RizzoCarla Rizzo
Carla Rizzo
NDNadka T. Dintcheva
Nadka T. Dintcheva
FGFrancesco GIANNICI
Francesco GIANNICI
Francesca D'AnnaFrancesca D'Anna
Francesca D'Anna

26 July 2018 in ACS Sustainable Chemistry & Engineering
Verified
Journal Article
Closed access
Carla RizzoCarla Rizzo
Carla Rizzo
Salvatore MarulloSalvatore Marullo
Salvatore Marullo
PCPaola R. Campodonico
Paola R. Campodonico
IPIvana Pibiri
Ivana Pibiri
NDNadka Tz. Dintcheva
Nadka Tz. Dintcheva
Francesca D'AnnaFrancesca D'Anna
Francesca D'Anna